Skip to main content
. 2022 Aug 23;22:311. doi: 10.1186/s12883-022-02824-w

Table 2.

Neuroimaging markers of SVD between As-CMI and Larger RSSI groups

As-CMI,
n = 23
Larger RSSI,
n = 561
Fully-adjusted*
OR(95%CI)
P value
Presence of Lacunes 14(60.9) 188(33.5) 2.88(1.21–6.84) 0.016
Lacunes number 0.039
  0 9(39.1) 373(66.5) Reference
  1 6(26.1) 102(18.2) 2.34(0.81–6.79) 0.115
  > 1 8(34.8) 86(15.3) 3.50(1.29–9.48) 0.013
The severity of WMH 0.060
  0–2 11(47.8) 310(55.3) Reference
  3–4 3(13.0) 154(27.5) 0.52(0.14–1.90) 0.323
  5–6 9(39.1) 97(17.3) 2.29(0.90–5.80) 0.081
The severity of EPVS in BG 0.391
  ≤ 10 5(21.7) 227(40.5) Reference
  11–20 13(56.5) 220(39.2) 2.07(0.68–6.28) 0.198
  > 20 5(21.7)) 114(20.3) 1.38(0.34–5.59) 0.645
The severity of EPVS in CSO 0.559
  ≤ 10 4(17.4) 76(13.5) Reference
  11–20 10(43.5) 287(51.2) 0.51(0.14–1.75) 0.285
  > 20 9(39.1) 198(35.3) 0.56(0.15–2.05) 0.383
Total CVSD Burden 2(1–3) 1 (0–2) 1.68(1.11–2.53) 0.013

Abbreviation: SVD, Cerebral small vessel disease; WMH, White matter hyperintensity; EPVS, Enlarged perivascular spaces; BG, Basal ganglia, CSO, Centrum semiovale

*Adjusted for age, sex, coronary artery disease